Biohaven migraine drug gets FDA green light

The has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults. NURTEC ODT is the first FDA-approved product for Biohaven.

“NURTEC ODT is an important new oral acute treatment for migraine that offers patients the potential to quickly reduce and eliminate pain and get back to their lives,” said Vlad Coric, M.D., CEO of Biohaven. more